USFDA approved Pfizer’s Abrilada, a biosimilar of Humira
Posted on19 Nov 2019
Comments0
The U.S. Food and Drug Administration (FDA) approved Pfizer’s Abrilada, a biosimilar of Humira. Pfizer said the FDA approved Abrilada (adalimumab-afzb) for the treatment of... Read More
Adalimumab Biosimilar Litigation: Sandoz’s settlement with AbbVie
Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with... Read More
Hyrimoz Sandoz’s biosimilar got European marketing approval
Posted on31 Jul 2018
Comments0
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the European Commission (EC) granted marketing authorization... Read More
The European Commission (EC) granted a marketing authorization of IMRALDI®, an adalimumab biosimilar
Posted on26 Aug 2017
TagsAdalimumab, Anti TNF therapy, BENEPALI, Biogen, Biosimilar, FLIXABI, humira, IMRALDI, Samsung Bioepis
Comments0
The European Commission (EC) granted a marketing authorization for IMRALDI® (also known as SB5), an adalimumab biosimilar referencing Humira®. IMRALDI has been... Read More
Amgen’s Amgevita, biosimilar of AbbVie’s Humira (adalimumab), has been approved by the European Commission
Reference Biologic – Humira (adalimumab) of AbbVie Biosimilar – Amgevita (adalimumab) of Amgen European Commission (EC) has granted marketing authorization for AMGEVITA™... Read More
Humira, (adalimumab), Abbvie – 2016 Biggest Patent Expiry and Biosimilar entry
Rheumatoid arthritis treatment Humira has long been a crucial source of revenue for AbbVie: the world’s biggest-selling drug accounted for 63% of... Read More
Torrent launched biosimilar for Adalimumab, under brand name Adfrar
Posted on12 Jan 2016
TagsAdalimumab, Adfrar, Exemptia, Toritz, Torrent launched biosimilar for Adalimumab, torrent pharma, under brand name Adfrar
Comments0
Ahmedabad-based drug major Torrent Pharmaceuticals launched its biosimilar for Adalimumab, a therapy for the treatment of auto immune disorders like rheumatoid arthritis... Read More
Torrent’s strategic alliance with Reliance Life Science for biosimilars
Torrent Pharmaceuticals Ltd , Ahmedabad based pharma company, has announced its entrance into an exclusive licensing agreement with Reliance Life Sciences for... Read More